Joseph Woodard
Direttore Tecnico/Scientifico/R&S presso IMUGENE LIMITED
Posizioni attive di Joseph Woodard
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMUGENE LIMITED | Direttore Tecnico/Scientifico/R&S | 04/09/2023 | - |
Storia della carriera di Joseph Woodard
Precedenti posizioni note di Joseph Woodard
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 11/01/2017 | 01/11/2019 |
Immune-Onc Therapeutics, Inc.
 Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Joseph Woodard
| The University of North Carolina at Charlotte | Undergraduate Degree |
| UNC School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Australia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| IMUGENE LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX. | Health Technology |
Immune-Onc Therapeutics, Inc.
Immune-Onc Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Immune-Onc Therapeutics, Inc. operates as a biopharmaceutical company focused on developing innovative therapeutic antibodies for cancer treatment. The company was founded by Charlene Liao and Gui-Liang Yu in 2016 and is headquartered in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- Joseph Woodard
- Esperienza
